✦ LIBER ✦

Sequence effect of docetaxel and carboplatin on toxicity, tumor response and pharmacokinetics in non-small-cell lung cancer patients: a phase I study of two sequences

✍ Scribed by Maki Ando; Hideo Saka; Yuichi Ando; Hironobu Minami; Takafumi Kuzuya; Masashi Yamamoto; Atsushi Watanabe; Shuzo Sakai; Kaoru Shimokata; Yoshinori Hasegawa

Book ID: 105992070
Publisher: Springer
Year: 2005
Tongue: English
Weight: 284 KB
Volume: 55
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-004-0921-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of second-line chemotherap

Phase I study of second-line chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer

✍ Mikio Oka; Minoru Fukuda; Seiji Nagashima; Masaaki Fukuda; Akitoshi Kinoshita; H 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 84 KB

Carboplatin and docetaxel in advanced no

Carboplatin and docetaxel in advanced non-small-cell lung cancer: results of a multicenter phase II study

✍ Sakkaraiappan Ramalingam; TracyW. Dobbs; AviI. Einzig; Slawomir Wojtowicz-Praga; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 181 KB

Phase I/II trial of docetaxel and carbop

Phase I/II trial of docetaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer

✍ Akira Shoji; Takashi Ogura; Kaneo Suzuki; Hiroshi Takahashi; Kenichi Takahashi; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 67 KB

A phase I pharmacokinetic study of bexar

A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)

✍ Jordi Rodon; Charlotte D. Jacobs; Quincy Chu; Eric K. Rowinsky; Arturo Lopez-Ana 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 277 KB

Phase I and pharmacokinetic study of car

Phase I and pharmacokinetic study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer

✍ M. Ichiki; R. Gohara; R. Fujiki; S. Hoashi; T. Rikimaru; H. Aizawa 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 214 KB

Phase I/II Trial of Docetaxel and Carbop

Phase I/II Trial of Docetaxel and Carboplatin as a First-Line Therapy in Patients with Stage IV Non-Small-Cell Lung Cancer

✍ Kensuke Kataoka; Ryujiro Suzuki; Hiroyuki Taniguchi; Yasunobu Noda; Joe Shindoh; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 82 KB